Home > Healthcare > Biotechnology > Biotechnology R&D > Biological Sample Collection Kits Market

Biological Sample Collection Kits Market Share

Report ID: GMI6002
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Biological Sample Collection Kits Market Share

Some of the major market players operating in the biological sample collection kits market are:

Thermo Fisher Scientific, Inc.
QIAGEN
FHoffmann-La Roche Ltd
Abbott Laboratories
Becton
Dickinson and Company
Laboratory Corporation of America Holdings
Seegene Inc.
Medline Industries Inc.

Major market players are adopting strategic formulations such as forward integration, new product development, geographical expansion, and research collaborations to garner maximum industry share and promote company growth.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Biological sample collection kits industry was worth around USD 7.8 billion in 2022 and is projected to reach over USD 18.6 billion by 2032 attributed to the high demand for biological sample collection kits in diagnostic and research applications.

The swabs segment accounted for more than USD 2.7 billion in 2022 and is set to grow at a steady pace, driven by the onset of the COVID-19 pandemic and the subsequent implementation of widespread testing to identify and control the spread of the virus.

U.S. market for biological sample collection kits surpassed USD 2.3 billion in 2022 owing to the presence of key market players and rising awareness regarding early-stage disease diagnosis.

Some of the leading firms engaged in the biological sample collection kits business are Thermo Fisher Scientific, Inc., QIAGEN, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company, and others.